These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Hepatitis delta and HIV infection. Calle Serrano B, Manns MP, Wedemeyer H. Semin Liver Dis; 2012 May; 32(2):120-9. PubMed ID: 22760651 [Abstract] [Full Text] [Related]
45. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists. Deming P, McNicholl IR. Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625 [Abstract] [Full Text] [Related]
46. Chronic viral hepatitis and use of interferon. Whom are we treating? Koretz RL. Postgrad Med; 1996 Sep; 100(3):55-7, 61-2, 68. PubMed ID: 8795646 [Abstract] [Full Text] [Related]
47. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients. Fernández-Montero JV, Vispo E, Barreiro P, Sierra-Enguita R, de Mendoza C, Labarga P, Soriano V. Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686 [Abstract] [Full Text] [Related]
49. Viral hepatitis: how to manage type C and D infections. Najm W. Geriatrics; 1997 May 15; 52(5):28-30, 33-4, 37. PubMed ID: 9152216 [Abstract] [Full Text] [Related]
50. Treatment of chronic viral hepatitis: the end of the beginning? Dusheiko G. Br J Hosp Med; 1997 May 15; 52(1):8-11. PubMed ID: 7524985 [No Abstract] [Full Text] [Related]
51. Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy. Kim AY, Chung RT, Polsky B. AIDS Clin Rev; 1997 May 15; ():263-306. PubMed ID: 10999223 [No Abstract] [Full Text] [Related]
52. [Form of progression of chronic hepatitis C with viral coinfection and additional liver diseases]. Hensel FJ, Heintges T, Petry W, Niederau C, Häussinger D. Dtsch Med Wochenschr; 1998 Feb 06; 123(6):161-6. PubMed ID: 9505956 [No Abstract] [Full Text] [Related]
53. Management of hepatic complications in HIV-infected persons. Sulkowski MS. J Infect Dis; 2008 May 15; 197 Suppl 3():S279-93. PubMed ID: 18447614 [Abstract] [Full Text] [Related]
54. [Hepatic manifestations of the acquired immunodeficiency syndrome (AIDS)]. Sakmann P, Pirovino M, Bansky G, Lüthy R, Malinverni R, Zimmerli W, Hirschel B. Schweiz Med Wochenschr; 1988 Jan 23; 118(3):82-8. PubMed ID: 3344412 [Abstract] [Full Text] [Related]
55. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users. Li JR, Gong RY, Tian KL, Wang J, Wang YX, Huang HJ. World J Gastroenterol; 2007 Apr 28; 13(16):2357-62. PubMed ID: 17511038 [Abstract] [Full Text] [Related]
56. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group. Soriano V, García-Samaniego J, Bravo R, González J, Castro A, Castilla J, Martínez-Odriozola P, Colmenero M, Carballo E, Suárez D, Rodríguez-Piñero FJ, Moreno A, del Romero J, Pedreira J, González-Lahoz J. Clin Infect Dis; 1996 Sep 28; 23(3):585-91. PubMed ID: 8879784 [Abstract] [Full Text] [Related]
57. Absent inhibition of hepatitis B virus replication by azidothymidine in patients chronically coinfected by HIV-1 and HBV. Gallian P, De Lamballerie X, Lehucher MP, Dhiver C, Ravaux I. New Microbiol; 1996 Apr 28; 19(2):167-9. PubMed ID: 8722313 [Abstract] [Full Text] [Related]